SQNMF Financials: Sequana Medical NV AI Analysis

Home

Stock

SQNMF

Financials

SQNMF Financial

Sequana Medical NV

0%

$0

At close: Mar 24, 16:00:00 GMT-4

$1.22

0%

$0

Post-market: Mar 24, 20:00:00 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

Open

Day's Range

52 week range

$0.78 - $3

Volume

Avg.Volume

350

Dividend yield

EPS (TTM)

Market Cap

$93.5M

What is SEQUANA MEDICAL NV?

Sequana Medical NV is a commercial stage medical device company, which engages in the design, development, manufacture, and commercialization of medical device. The company is headquartered in Ghent, Oost-Vlaanderen and currently employs 48 full-time employees. The company went IPO on 2019-02-11. The firm focuses mainly on the development of treatment solutions for the management of liver disease, heart failure, malignant ascites and other fluid imbalance disorders. Sequana Medical NV provides alfapump, which is an implantable, programmable, wireless-charged and battery-powered system that is CE-marking for the management of refractory ascites due to liver cirrhosis and malignant ascites. Over 650 alfapump systems have been implanted. Apart from the Alfapump, the Company also aims to develop a direct sodium removal (DSR) therapy, which is a propriety approach to the treatment of volume overload in heart failure.



Features

AI Copilot for Stock & Crypto

Resources

Market

Income

Balance sheet

Cash flow

Annual

Quarterly

SQNMF Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	3	3	4	3	2	1
Gross Profit	-3	-3	-4	-2	-2	0
Selling, General & Admin	8	7	8	8	7	6
Research & Development	--	--	--	--	--	--
Operating Expenses	13	14	24	25	20	16
Other Non Operating Income (Expenses)	0	0	0	0	--	0
Pretax Income	-51	-44	-32	-30	-23	-18
Income Tax Expense	0	0	0	0	0	0
Net Income	-51	-44	-32	-30	-23	-19
Net Income Growth	89%	38%	7%	30%	21%	36%
Shares Outstanding (Diluted)	52.41	36.74	26.77	22.76	18.21	15.31
Shares Change (YoY)	46%	37%	18%	25%	19%	25%
EPS (Diluted)	-0.98	-1.21	-1.21	-1.35	-1.29	-1.24
EPS Growth	31%	0%	-10%	4%	4%	2%
Free Cash Flow	-17	-20	-29	-28	-23	-17
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	0%	0%	0%	0%	0%	0%
Operating Margin	0%	0%	0%	0%	0%	0%
Profit Margin	0%	0%	0%	0%	0%	0%
Free Cash Flow Margin	0%	0%	0%	0%	0%	0%
EBITDA	-16	-18	-28	-28	-22	-17
EBITDA Margin	0%	0%	0%	0%	0%	0%
D&A For EBITDA	1	0	0	0	0	0
EBIT	-17	-18	-28	-28	-22	-17
EBIT Margin	0%	0%	0%	0%	0%	0%
Effective Tax Rate	0%	0%	0%	0%	0%	0%

Follow-Up Questions

What are Sequana Medical NV's key financial statements?



According to the latest financial statement (Form-10K), Sequana Medical NV has a total asset of $9, Net loss of $-44

What are the key financial ratios for SQNMF?



Sequana Medical NV's Current ratio is 0.16, has a Net margin is 0, sales per share of $0.

How is Sequana Medical NV's revenue broken down by segment or geography?



Sequana Medical NV largest revenue segment is Medical Device, at a revenue of 712,173 in the most earnings release.For geography, Germany is the primary market for Sequana Medical NV, at a revenue of 553,500.

Is Sequana Medical NV profitable?



no, according to the latest financial statements, Sequana Medical NV has a net loss of $-44

Does Sequana Medical NV have any liabilities?



yes, Sequana Medical NV has liability of 54

How many outstanding shares for Sequana Medical NV?



Sequana Medical NV has a total outstanding shares of 44.43

Sequana Medical NV (SQNMF) Financial

SQNMF Stock Price Chart